Abstract
Cell membranes bearing the appropriate antigen are known to stimulate a variety of cellmediated immune responses. This report confirms that tumor cell membranes at doses of 2-5 μg protein/ml will stimulate in vitro generation of allogeneic cytotoxic T lymphocytes (CTL). However, higher doses (50-100 μg protein/ml) of the same membranes completely abrogate the generation of lytic activity. Responding lymphocytes are inhibited by membranes from either syngeneic or allogeneic cells. The inhibition appears to act at a proliferative or differentiation step in the generation of the CTL response, since membranes are known to have little direct effect on the lytic phase of CTL activity. Similar doses of membranes also inhibit LPS-induced B-cell proliferation. B-Cell proliferation is inhibited equally well by allogeneic and syngeneic membranes, and membranes from normal spleen cells are as inhibitory as tumor cell membranes. The inhibitory activity copurifies with the plasma membrane. The results raise important considerations regarding the use of subcellular forms of antigen in studies of lymphocyte recognition. In addition, these data suggest that cell-cell contacts might provide signals regulating the proliferation of lymphocytes.
Original language | English (US) |
---|---|
Pages (from-to) | 144-150 |
Number of pages | 7 |
Journal | Cellular Immunology |
Volume | 89 |
Issue number | 1 |
DOIs | |
State | Published - Nov 1984 |
Externally published | Yes |
Bibliographical note
Funding Information:’ This work was supported by National Institutes of Health Grants CA-14723 (M. F. Mescher), AI-17258 (S. J. Burakolf), and American Cancer Society, Massachusetts Division, Grant IS16-C-l (M. F. Mescher). 2 K. C. Stallcup was supported by a Leukemia Society Special Fellowship. 3 S. J. Burakoff is a recipient of an Americn Cancer Society Faculty Research Award. 4 Abbreviations used: CTL, cytotoxic T lymphocyte; LPS, Iipopolysaccharide; CM, crude membrane(s); PM, plasma membrane(s); ER, endoplasmic reticulum; TdR, thymidine.